Barriers to lung cancer care: health professionals’ perspectives

Abstract

PurposeGlobally, lung cancer is the most common cancer and the leading cause of cancer death. Problematically, there is a wide variation in the management and survival for people with lung cancer and there is limited understanding of the reasons for these variations. To date, the views of health professionals across relevant disciplines who deliver such care are largely absent. The present study describes Australian health professionals’ views about barriers to lung cancer care to help build a research and action agenda for improving lung cancer outcomes.MethodsQualitative semi-structured interviews were undertaken with a multidisciplinary group of 31 Australian health professionals working in lung cancer care for an average of 16 years (range 1–35 yrs.; SD = 10.2) seeing a mean of 116 patients annually.ResultsThree superordinate themes were identified: illness representations, cultural influences, and health system context. Illness representations included three themes: symptoms attributed as smoking-related but not cancer, health-related stigma, and therapeutic nihilism. Cultural influence themes included Indigenous health care preferences, language and communication, and sociodemographic factors. Health system context included lack of regional services and distance to treatment, poor care coordination, lack of effective screening methods, and health professional behaviours.ConclusionsFractured and locally isolated approaches routinely confound responses to the social, cultural and health system complexities that surround a diagnosis of lung cancer and subsequent treatment. Improving outcomes for this disadvantaged patient group will require government, health agencies, and the community to take an aggressive, integrated approach balancing health policy, treatment priorities, and societal values.Electronic supplementary materialThe online version of this article (doi:10.1007/s00520-016-3428-3) contains supplementary material, which is available to authorized users.

<p>Characterization of Phenotypic and Genotypic Traits of <em>Klebsiella pneumoniae</em> from Lung Cancer Patients with Respiratory Infection</p>

“…Globally, lung cancer is the most common cancer, contributing to one in five cancer deaths. 21 Although the operative mortality after lung resection has decreased over the past decades, the mortality rate from postoperative pneumonia following lung cancer surgery remains significant. 22 Patients with cancer are more likely to suffer from infection due to pathogenic bacteria than benign patients.…”

Timely follow‐up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium

“…These suboptimal rates may reflect appropriate shared clinical decisions to forgo further testing, or they may stem from social, cultural, financial, structural, or other barriers at individual, provider, or system levels. Such factors include low socioeconomic status, employment status, rurality, perceived discrimination, or health‐related stigma . Provider‐related and system‐related problems with care delivery are crucial .…”

“…Such factors include low socioeconomic status, employment status, rurality, perceived discrimination, or healthrelated stigma. 23,69,91,[124][125][126][127][128][129][130] Provider-related and system-related problems with care delivery are crucial. 3,124 The method of result notification (with telephone and letter notification associated with longer delays than in-person notification), as well as the use of navigators, rapid diagnostic units, and organized screening programs, influence the timeliness of followup.…”

Contemporary consumer perspectives on prostate cancer survivorship: Fifty voices

“…However, the voice of the cancer survivor is not routinely visible in survivorship care initiatives and guidelines, and services developed in the absence of a patient voice risk being inaccessible or irrelevant to the individuals they seek to serve. This is a particular issue for patient groups who by virtue of their illness type or sociodemographic and cultural background may less likely to advocate on their own behalf . Mitigating this risk by actively engaging cancer survivors in the development and delivery of survivorship care initiatives is encapsulated in the concept of co‐production.…”

“…This is a particular issue for patient groups who by virtue of their illness type or sociodemographic and cultural background may less likely to advocate on their own behalf. 9,10 Mitigating this risk by actively engaging cancer survivors in the development and delivery of survivorship care initiatives is encapsulated in the concept of coproduction. Shifting from the traditional bio-medical view of health care as a "product" delivered by clinicians to passive patients, to health care as a "service" co-produced collaboratively between patients, clinicians and health care systems embeds a role for patients as actors in their own health care.…”